From: Mapping EORTC QLQ-C30 and FACT-G onto EQ-5D-5L index for patients with cancer
Whole sample | ninefold cross-validation | |||||
---|---|---|---|---|---|---|
RMSE | MAE | ρ | RMSE | MAE | ρ | |
EORTC QLQ-C30 | ||||||
Linear | 0.099 | 0.075 | 0.838 | 0.100 | 0.076 | 0.833 |
Beta | 0.103 | 0.081 | 0.825 | 0.105 | 0.081 | 0.817 |
Tweedie | 0.110 | 0.084 | 0.803 | 0.114 | 0.086 | 0.799 |
Tobit | 0.102 | 0.077 | 0.836 | 0.103 | 0.078 | 0.822 |
Two-part linear | 0.100 | 0.075 | 0.837 | 0.101 | 0.076 | 0.825 |
Two-part beta | 0.099 | 0.075 | 0.840 | 0.101 | 0.077 | 0.828 |
Ordinal logistic | 0.100 | 0.077 | 0.835 | 0.101 | 0.078 | 0.829 |
FACT-G | ||||||
Linear | 0.121 | 0.090 | 0.753 | 0.121 | 0.091 | 0.744 |
Beta | 0.121 | 0.091 | 0.754 | 0.122 | 0.092 | 0.752 |
Tweedie | 0.124 | 0.092 | 0.740 | 0.124 | 0.093 | 0.740 |
Tobit | 0.123 | 0.090 | 0.754 | 0.124 | 0.091 | 0.751 |
Two-part linear | 0.122 | 0.091 | 0.749 | 0.123 | 0.092 | 0.748 |
Two-part beta | 0.119 | 0.090 | 0.760 | 0.121 | 0.091 | 0.759 |
Ordinal logistic | 0.119 | 0.090 | 0.760 | 0.120 | 0.091 | 0.764 |